OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine
Stefania Forciniti, Elisa Dalla Pozza, Maria Raffaella Greco, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 29-29
Open Access | Times Cited: 18

Showing 18 citing articles:

Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2486-2486
Open Access | Times Cited: 65

Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
Miguel Pereira‐Silva, Darío Miranda-Pastoriza, Luis Díaz‐Gómez, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 95-95
Open Access | Times Cited: 9

Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches
Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6135-6135
Open Access | Times Cited: 42

Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy
Li Liu, Shanshan Han, Xi Xiao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 22

3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death
Raffaella Pacchiana, Nidula Mullappilly, Andrea Pinto, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3153-3153
Open Access | Times Cited: 16

Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
Taiyu Song, Bin Kong, Rui Liu, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 1
Closed Access | Times Cited: 9

Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
Stefania Cannone, Maria Raffaella Greco, Tiago M. A. Carvalho, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3737-3737
Open Access | Times Cited: 15

Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma
Justyna Budka, Dawid Dębowski, Shaoshan Mai, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 283-283
Open Access | Times Cited: 2

Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell
Diana Tavares‐Valente, Stefania Cannone, Maria Raffaella Greco, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3868-3868
Open Access | Times Cited: 5

Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected Pancreatic Cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemcitabine
Tiago M. A. Carvalho, Madelaine Magalì Audero, Maria Raffaella Greco, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 730-730
Open Access | Times Cited: 1

Cost-Effective Real-Time Metabolic Profiling of Cancer Cell Lines for Plate-Based Assays
Wiktoria Błaszczak, Zhengchu Tan, Pawel Swietach
Chemosensors (2021) Vol. 9, Iss. 6, pp. 139-139
Open Access | Times Cited: 9

ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells
Daria Di Molfetta, Stefania Cannone, Maria Raffaella Greco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10632-10632
Open Access | Times Cited: 3

Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2022-2022
Open Access | Times Cited: 4

Substrate softness increases magnetic microdiscs-induced cytotoxicity
Adriana Visonà, Sébastien Cavalaglio, S. Labau, et al.
Nanoscale Advances (2024) Vol. 7, Iss. 1, pp. 219-230
Open Access

Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer
Yun Xi, Hong Chen, Yue Xi, et al.
Nuclear Medicine and Biology (2023) Vol. 120-121, pp. 108350-108350
Closed Access | Times Cited: 1

Promising 3D <em>in vitro</em> models for studying tumour heterogeneity and testing novel therapeutic approaches in pancreatic cancer
Stefania Forciniti, Marta Cavo, Ilaria Dando, et al.
Biomedical Science and Engineering (2021) Vol. 4, Iss. s1
Open Access

Page 1

Scroll to top